TELSTRIP-AM Tablets combines an ARB and a calcium channel blocker to deliver superior blood pressure control. Telmisartan reduces vascular resistance, while Amlodipine improves arterial dilation, offering complementary and sustained antihypertensive action. This combination is ideal for patients with moderate to severe hypertension not adequately controlled by monotherapy. TELSTRIP-AM helps reduce cardiovascular complications and improves treatment adherence. Marketed by Varmed Pharma Pvt Ltd, TELSTRIP-AM is a high-demand product under the PCD Pharma Franchise model.